Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study.

Saved in:
Bibliographic Details
Title: Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study.
Authors: Thompson W; Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, British Columbia, Canada.; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Women's College Research Institute, Toronto, Ontario, Canada., Yu B; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Porter J; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Fang J; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Ferreira-Legere LE; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Austin PC; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Research Institute, Toronto, Ontario, Canada., Jackevicius CA; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Western University of Health Sciences, Pomona, California, USA., Ross H; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.; Toronto General Hospital Research Institute, Toronto, Ontario, Canada., Lee DS; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Weisman A; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Farkouh ME; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.; Heart and Stroke/Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada., Gershon AS; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Research Institute, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Atzema CL; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Research Institute, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Kwong JC; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Department of Family & Community Medicine and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Public Health Ontario, Toronto, Ontario, Canada.; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; University Health Network, Toronto, Ontario, Canada., Ha A; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.; Toronto General Hospital Research Institute, Toronto, Ontario, Canada., Džavík V; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada., Udell JA; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada jay.udell@utoronto.ca.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
Source: BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2025 Aug 07; Vol. 13 (4). Date of Electronic Publication: 2025 Aug 07.
Publication Type: Journal Article
Journal Info: Publisher: Published by BMJ in partnership with the American Diabetes Association Country of Publication: England NLM ID: 101641391 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4897 (Electronic) Linking ISSN: 20524897 NLM ISO Abbreviation: BMJ Open Diabetes Res Care Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2052-4897
DOI:10.1136/bmjdrc-2024-004677